Literature DB >> 23916573

Biosimilar G-CSF (filgrastim) is effective for peripheral blood stem cell mobilization and non-cryopreserved autologous transplantation.

N Yafour1, M Brahimi, S Osmani, A Arabi, R Bouhass, M A Bekadja.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23916573     DOI： 10.1016/j.tracli.2013.04.109

Source DB:  PubMed          Journal:  Transfus Clin Biol        ISSN： 1246-7820            Impact factor:   1.406


× No keyword cloud information.
  2 in total

Review 1.  Biosimilar G-CSF based mobilization of peripheral blood hematopoietic stem cells for autologous and allogeneic stem cell transplantation.

Authors:  Michael Schmitt; Amy Publicover; Kim H Orchard; Matthias Görlach; Lei Wang; Anita Schmitt; Jiju Mani; Panagiotis Tsirigotis; Reeba Kuriakose; Arnon Nagler
Journal:  Theranostics       Date:  2014-01-23       Impact factor: 11.556

Review 2.  Biosimilar granulocyte-colony-stimulating factor for healthy donor stem cell mobilization: need we be afraid?

Authors:  Halvard Bonig; Petra S Becker; Arnd Schwebig; Matthew Turner
Journal:  Transfusion       Date:  2014-06-26       Impact factor: 3.157
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.